Anastasia Lanzi

Title: Anastasia Lanzi: Innovator in Adenovirus Vaccine Development

Introduction

Anastasia Lanzi is a prominent inventor based in Utrecht, Netherlands. She has made significant contributions to the field of vaccine development, particularly through her innovative work on adenovirus vaccine vectors. Her research focuses on creating recombinant adenoviruses that can effectively generate immune responses.

Latest Patents

Anastasia Lanzi holds 1 patent for her invention related to adenovirus vaccine vectors. This invention involves recombinant adenoviruses that display one or more heterologous epitopes on their fiber protein. These recombinant adenoviruses are particularly useful as vaccines for individuals with pre-existing anti-Ad immunity, allowing for effective immune responses against specific epitopes.

Career Highlights

Anastasia is affiliated with the Institut Gustave Roussy, where she continues her groundbreaking research. Her work has positioned her as a key figure in the development of innovative vaccine strategies, contributing to advancements in immunology and public health.

Collaborations

Throughout her career, Anastasia has collaborated with notable colleagues, including Karim Benihoud and Michel Perricaudet. These partnerships have enhanced her research efforts and expanded the impact of her work in the scientific community.

Conclusion

Anastasia Lanzi is a trailblazer in the field of vaccine innovation, with her work on adenovirus vaccine vectors paving the way for new therapeutic approaches. Her contributions are vital in the ongoing fight against infectious diseases, showcasing the importance of innovation in healthcare.